-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Vir Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$214M, a 30.8% decline year-over-year.
- Vir Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$533M, a 11.2% increase year-over-year.
- Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$615M, a 219% decline from 2022.
- Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $516M, a 2.41% decline from 2021.
- Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $529M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)